ArticleInternational forum of allergy & rhinology2026
Oral Steroid Use and Asthma Comorbidity in Central Compartment Atopic Disease: The Predictive Role of Olfactory Dysfunction and Eosinophilia.
Article in International forum of allergy & rhinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundCentral compartment atopic disease (CCAD) is a distinct phenotype of chronic rhinosinusitis with nasal polyps (CRSwNP), characterized by central nasal cavity inflammation. Although well described in Western populations, data from East Asia remain limited. We aimed to characterize CCAD's clinical features, identify predictors of postoperative oral corticosteroid (OCS) use, and explore CCAD's association with comorbid asthma.
methodsIn this propensity score-matched case-control study, patients with bilateral CRSwNP were classified as CCAD or non-CCAD using endoscopic findings. Clinical characteristics, laboratory markers, and surgical outcomes were compared. Subgroup analysis within CCAD evaluated predictors of postoperative OCS use and comorbid asthma.
resultsCompared with non-CCAD CRSwNP, CCAD patients had more severe subjective olfactory dysfunction (p = 0.035) and a distinct allergic inflammatory profile, including higher blood and tissue eosinophils, serum immunoglobulin E, and eosinophil cationic protein. Within the CCAD cohort, patients requiring postoperative OCS use had greater tissue eosinophilia; a threshold of ≥ 21 cells/high-power field independently predicted OCS need (hazard ratio = 12.4, 95% confidence interval = 1.6-93.4, p = 0.015). Comorbid asthma was associated with higher Lund-Mackay scores and blood eosinophilia (p = 0.012 and p = 0.007, respectively).
conclusionsCCAD is associated with greater subjective olfactory dysfunction and a distinct allergic inflammatory profile. Tissue eosinophilia independently predicts postoperative corticosteroid use, while advanced disease and elevated blood eosinophils predict comorbid asthma. These findings support risk stratification and personalized postoperative management in CCAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.